Interestingly, double immunostaining showed that pathological translocation of TDP-43 was significantly reduced in LDN-212320-treated YAPGFAP-CKO ALS mice, and TDP-43 was primarily expressed in the nucleus of neurons (Figure 8L, N). The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.